CN102596915B - 2-硫代组氨酸及类似物的合成方法 - Google Patents

2-硫代组氨酸及类似物的合成方法 Download PDF

Info

Publication number
CN102596915B
CN102596915B CN201080047020.4A CN201080047020A CN102596915B CN 102596915 B CN102596915 B CN 102596915B CN 201080047020 A CN201080047020 A CN 201080047020A CN 102596915 B CN102596915 B CN 102596915B
Authority
CN
China
Prior art keywords
general formula
compound
acid
enantiomers
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201080047020.4A
Other languages
English (en)
Chinese (zh)
Other versions
CN102596915A (zh
Inventor
I·艾德麦尔
S·多奈
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tetrahedron SAS
Original Assignee
Tetrahedron SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tetrahedron SAS filed Critical Tetrahedron SAS
Publication of CN102596915A publication Critical patent/CN102596915A/zh
Application granted granted Critical
Publication of CN102596915B publication Critical patent/CN102596915B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B55/00—Racemisation; Complete or partial inversion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN201080047020.4A 2009-10-06 2010-10-06 2-硫代组氨酸及类似物的合成方法 Expired - Fee Related CN102596915B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0956968 2009-10-06
FR0956968A FR2950890B1 (fr) 2009-10-06 2009-10-06 Procede de synthese de la 2-thiohistidine et analogues
PCT/EP2010/064947 WO2011042478A1 (fr) 2009-10-06 2010-10-06 Procede de synthese de la 2-thiohistidine et analogues

Publications (2)

Publication Number Publication Date
CN102596915A CN102596915A (zh) 2012-07-18
CN102596915B true CN102596915B (zh) 2016-04-20

Family

ID=41664356

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201080047020.4A Expired - Fee Related CN102596915B (zh) 2009-10-06 2010-10-06 2-硫代组氨酸及类似物的合成方法

Country Status (14)

Country Link
US (1) US8835477B2 (cg-RX-API-DMAC7.html)
EP (1) EP2486019B1 (cg-RX-API-DMAC7.html)
JP (1) JP5731515B2 (cg-RX-API-DMAC7.html)
KR (1) KR101773995B1 (cg-RX-API-DMAC7.html)
CN (1) CN102596915B (cg-RX-API-DMAC7.html)
AU (1) AU2010305397B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012007944A2 (cg-RX-API-DMAC7.html)
CA (1) CA2776833C (cg-RX-API-DMAC7.html)
ES (1) ES2540279T3 (cg-RX-API-DMAC7.html)
FR (1) FR2950890B1 (cg-RX-API-DMAC7.html)
HU (1) HUE025487T2 (cg-RX-API-DMAC7.html)
IN (1) IN2012DN03819A (cg-RX-API-DMAC7.html)
RU (1) RU2548153C2 (cg-RX-API-DMAC7.html)
WO (1) WO2011042478A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3021655B1 (fr) 2014-05-30 2016-07-08 Tetrahedron Nouveaux composes de type 5-acylsulfanyl-histidine en tant que precurseurs des 5-sulfanylhistidines correspondantes et de leurs disulfures
JP6864131B1 (ja) 2020-03-04 2021-04-28 長瀬産業株式会社 Ｌ−エルゴチオネイン含有組成物
EP4326302A4 (en) * 2021-04-22 2025-03-05 University of Vermont and State Agricultural College SUBSTITUTION OF HISTIDINE BY 2-THIOHISTIDINE IN BIOACTIVE PEPTIDES

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707087B1 (fr) * 1993-06-28 1995-10-13 Bioxytech Nouveau procédé de préparation de l'ergothionéine.
FR2714380B1 (fr) 1993-12-24 1996-05-24 Bioxytech Utilisation de dérivés 2-mercapto-imidazole substitués en position 4 (ou 5) comme agents antioxydants, leur procédé de préparation et leurs applications en pharmacie, cosmétique ou alimentaire.
KR20000067963A (ko) * 1996-07-22 2000-11-25 죤 에이치. 뷰센 티올 술폰 메탈로프로테아제 저해제
BR0114619A (pt) * 2000-10-11 2005-12-13 Esperion Therapeutics Inc Composto, composição farmacêutica, métodos para tratar ou prevenir uma doença cardiovascular, uma dislipidemia, uma dislipoproteinemia, um distúrbio do metabolismo da glicose, trombótico e associado com o receptor ativado do proliferador de peroxissoma, a doença de alzheimer, a sìndrome x ou sìndrome metabólica, a septicemia, a obesidade, pancreatite, a hipertensão, doença renal, câncer, a inflamação e a impotência, em um paciente e para reduzir o teor de gordura da carne em animal de criação e de colesterol de ovos de aves domésticas
US7767826B2 (en) * 2007-10-05 2010-08-03 Pharmatech International, Inc. Process for the synthesis of L-(+)-ergothioneine
FR2950889B1 (fr) 2009-10-06 2011-11-18 Tetrahedron Procede de synthese de l'ergothioneine et analogues

Also Published As

Publication number Publication date
AU2010305397A1 (en) 2012-05-24
JP2013506705A (ja) 2013-02-28
US8835477B2 (en) 2014-09-16
AU2010305397B2 (en) 2014-07-10
US20120330029A1 (en) 2012-12-27
KR20120100977A (ko) 2012-09-12
HUE025487T2 (en) 2016-04-28
WO2011042478A1 (fr) 2011-04-14
EP2486019A1 (fr) 2012-08-15
EP2486019B1 (fr) 2015-03-25
RU2012117977A (ru) 2013-11-20
CA2776833A1 (fr) 2011-04-14
FR2950890A1 (fr) 2011-04-08
JP5731515B2 (ja) 2015-06-10
BR112012007944A2 (pt) 2015-09-22
IN2012DN03819A (cg-RX-API-DMAC7.html) 2015-08-28
CA2776833C (fr) 2019-03-19
KR101773995B1 (ko) 2017-09-01
ES2540279T3 (es) 2015-07-09
FR2950890B1 (fr) 2011-12-30
RU2548153C2 (ru) 2015-04-20
CN102596915A (zh) 2012-07-18

Similar Documents

Publication Publication Date Title
AU2010305399B2 (en) Method for the synthesis of ergothioneine and the like
CN102596915B (zh) 2-硫代组氨酸及类似物的合成方法
CN106573895B (zh) 作为相应的5-硫烷基组氨酸和其二硫化物的前体的新型5-酰基硫烷基-组氨酸化合物
HU229391B1 (hu) Intermedierek kinolonkarbonsav-származékok elõállítására
JP3125101B2 (ja) 光学異性ヒダントインの分割方法
CZ298472B6 (cs) Zpusob výroby substituovaného alkylaminu nebo jeho soli
CZ20013403A3 (cs) Způsob přípravy kyseliny 3S-3-amino-3-arylpropionové a jejich derivátů
WO2023006986A1 (en) Method for preparing and purifying an agent suitable for treating anemia
JP2003081971A (ja) ５−ピリジルメチルヒダントイン化合物及びｎ−カルバモイル−３−（ピリジル）アラニン化合物
Rudyakova et al. Synthesis of (1 H-pyrrol-2-ylsulfanyl) alkanoic acids
CA2192798A1 (en) Thiazoline derivative
JPH03170486A (ja) 新規なオキサゾピロロキノリン化合物
JPH04198172A (ja) ヒダントイン誘導体の製造方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160420

Termination date: 20211006

CF01 Termination of patent right due to non-payment of annual fee